Smiths Detection Wins approximately $7m Chemical Detector Order
July 25, 2013
Edgewood, MD,- Smiths Detection today announced a follow-on production order worth approximately $7 million from the U.S. Army under the Department of Defense’s Joint Chemical Agent Detector (JCAD) program. Lance Roncalli, Vice President of Sales, Americas, Smiths Detection, said: “This order underscores the Department of Defense’s continued commitment to one of the largest, most effective [...]
Life Technologies Expands CEERAM Food Safety Range to Global Market
July 25, 2013
CARLSBAD, Calif., -- Life Technologies Corporation (NASDAQ: LIFE) today announced the expansion of its global food safety portfolio with the worldwide distribution of the RT-qPCR assays for the detection of Norovirus GI and Norovirus GII, Hepatitis A, and theMengovirus Extraction Control Kit by CEERAM (the European Centre for Expertise and Research on Microbial Agents). Available [...]
Quantachrome Instruments announces the release of the new XeriPrep™ sample preparation degasser.
July 25, 2013
This degasser is used to dry (Xeri is derived from the Greek word “xeros” meaning “dry”), samples prior to surface area and pore size analysis by gas sorption. The XeriPrep™ can be used with a variety of Quantachrome’s gas sorption analyzers including the Autosorb® 6 iSA™, Autosorb® iQ, Nova™ Series, Quadrasorb™, and iSorb™. Consistent and [...]
July 25, 2013
Ipswich, MA – NEBsolutions, a dedicated team of customized reagent and service specialists at New England Biolabs® (NEB), is pleased to offer a suite of reagents and capabilities for molecular diagnostics (MDx) product development, at this year’s Annual Meeting of the American Association of Clinical Chemistry (AACC). NEB, a leader in the development and production [...]
Dotmatics Cloud Hosted Platform Enables AstraZeneca Neuroscience Drug Discovery Collaborations
July 25, 2013
Bishops Stortford, UK. Dotmatics announced today that the AstraZeneca Neuroscience Innovative Medicines Unit (iMed) has selected its Cloud based informatics platform as their research data management solution. The Dotmatics platform provides a single point of access to all data and functions across multidisciplinary groups. The platform includes compound registration and tracking, biological screening, DMPK analysis, [...]
July 25, 2013
PARIS, - Mauna Kea Technologies (NYSE Euronext: MKEA, FR0010609263), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, has entered several distribution agreements for its line of Cellvizio LAB products, including the Cellvizio Dual Band, for preclinical research. With new partnerships in place in North America, Taiwan, Italy, [...]
July 25, 2013
BASINGSTOKE, United Kingdom -- Food microbiology laboratories can now confidently test to a recognized standard forListeria monocytogenes with the Thermo Scientific SureTect Listeria monocytogenes Assay, which has been granted Performance Tested MethodSM status by the AOAC Research Institute. Listeria monocytogenes can be present in a variety of foodstuffs, including some processed meats and cheeses, and [...]
Marks Company’s 17th Patent Issued
July 25, 2013
WILMINGTON, MA -- Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced the United States Patent and Trademark Office has issued the Company patent #8,469,295, titled "Trace Chemical Particle Release Nozzle." This patent relates to a method of leveraging air jets and/or aerosols [...]
Eurofins Panlabs strengthens drug discovery services with GE Healthcare’s Cytiva™ Cardiomyocytes
July 25, 2013
Eurofins Scientific (EUFI.PA), the world leader in food, environment and pharmaceutical products testing, has signed an agreement with GE Healthcare for the exclusive right to offer GE Healthcare’s Cytiva™ Cardiomyocytes for drug discovery and early development cardio toxicity screening services. The agreement allows Eurofins Panlabs to provide a unique offering for an early predictive measure [...]
Trovagene Announces Issuance of Broad MicroRNA Patent
July 24, 2013
SAN DIEGO, -- Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, announced the issuance of US patent 8,486,626, "Methods of detecting cell-free miRNA in urine and blood." The patent pertains to the detection and quantitation of microRNA (miRNA) using a wide variety of technologies and platforms. MicroRNAs are known to play critical roles [...]
